Target intelligence / Profile preview

ZNF594 divergent transcript (ZNF594-DT)

Target
ZNF594-DT
Molecular classification
Other (long non-coding RNA / lncRNA)
01

Overview

ZNF594 divergent transcript (ZNF594-DT) is a long non-coding RNA (lncRNA) gene found in humans, annotated with the official symbols ENSG00000261879 (Ensembl) and 100130950 (NCBI). It is classified as a non-coding RNA, meaning it is transcribed into RNA but does not encode a protein product[3][5][6]. There is no published evidence as of September 2025 that ZNF594-DT is a direct therapeutic target, biomarker, or has a defined protein-like mechanism of action. Its biological role remains unknown, although lncRNAs generally may act in the regulation of gene expression, chromatin modification, or other diverse cellular processes[5][6]. There are no known disease associations, safety concerns, or drugs that interact with this transcript at present. ZNF594-DT (ZNF594 divergent transcript) is a human long non-coding RNA with no established biological or disease roles, drug interactions, or function as a therapeutic or diagnostic target[5][6][3].

Other names
ZNF594 divergent transcriptZNF594-DT
02

Mechanism of action

none (not known to be directly targeted by drugs)

03

Biological functions

Other (specific function unknown; generic lncRNA regulatory roles possible)
04

Disease associations

Other (no established direct disease role as of current knowledge; there is no evidence associating ZNF594-DT directly with specific diseases)

Beyond the preview

Go deeper on ZNF594 divergent transcript (ZNF594-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF594 divergent transcript (ZNF594-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call